The Antitumor Effect of Topotecan Loaded Thiolated Chitosan-Dextran Nanoparticles for Intravitreal Chemotherapy: A Xenograft Retinoblastoma Model.

Purpose: This research intended to fabricate the thiolated chitosan-dextran nanoparticles (NPs) containing topotecan (TPH-CMD-TCS-NPs) to assess the ability of NPs in improving the efficacy of intravitreal chemotherapy of retinoblastoma in a rabbit xenograft model. Methods: The coacervation process...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Ophthalmic & Vision Research Vol. 18; no. 1; pp. 68 - 81
Autores principales: Delrish, Elham, Jabbarvand, Mahmoud, Ghassemi, Fariba, Amoli, Fahimeh Asadi, Atyabi, Fatemeh, Keshel, Saeed Heidari, Lashay, Alireza, Mirzazadeh Tekie, Farnaz Sadat, Soleimani, Masoud, Dinarvand, Rassoul
Formato: diagnostic images pictorial research tables/charts Journal Article
Publicado: Knowledge E DMCC Jan-Mar2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=162044642&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 162044642
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20082010
        AY5S
      jtl: Journal of Ophthalmic & Vision Research
      issn: 20082010
      maglogo: N
    pubinfo:
      dt: Jan-Mar2023
      vid: 18
      iid: 1
      pid: 35682
      pub: Knowledge E DMCC
    artinfo:
      ui:
        162044642
        162044642
        162044642
        10.18502/jovr.v18i1.12727
        162044642
      ppf: 68
      ppct: 13
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: The Antitumor Effect of Topotecan Loaded Thiolated Chitosan-Dextran Nanoparticles for Intravitreal Chemotherapy: A Xenograft Retinoblastoma Model.
      aug:
        au:
          Delrish, Elham
          Jabbarvand, Mahmoud
          Ghassemi, Fariba
          Amoli, Fahimeh Asadi
          Atyabi, Fatemeh
          Keshel, Saeed Heidari
          Lashay, Alireza
          Mirzazadeh Tekie, Farnaz Sadat
          Soleimani, Masoud
          Dinarvand, Rassoul
        affil: Translational Ophthalmology Research Centre (TORC), Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
      sug:
        subj:
          Retinoblastoma Drug Therapy
          Topotecan Therapeutic Use
          Polysaccharides Administration and Dosage
          Dextrans Administration and Dosage
          Nanoparticle Drug Delivery System
          Chemotherapy, Cancer
          Xenografts
          Animal Studies
          Rabbits
          Topotecan Administration and Dosage
          Microscopy Methods
          Eye Drug Effects
          Dyes
          Flow Cytometry
          Injections
          Necrosis
          Staining and Labeling Methods
          Tumor Burden
          Calorimetry
          Time Factors
          Outcome Assessment
          Kruskal-Wallis Test
          Data Analysis Software
          Post Hoc Analysis
          Descriptive Statistics
          Funding Source
      ab: Purpose: This research intended to fabricate the thiolated chitosan-dextran nanoparticles (NPs) containing topotecan (TPH-CMD-TCS-NPs) to assess the ability of NPs in improving the efficacy of intravitreal chemotherapy of retinoblastoma in a rabbit xenograft model. Methods: The coacervation process was used to produce the NPs. The cellular uptake of Cyanine-3 (CY3)-labeled NPs were investigated in human retinoblastoma Y79 cells using confocal microscopy. Also, the prepared TPH-CMD-TCS-NPs were tested in vitro by the tetrazolium dyes II (XTT) and flow cytometry in order to assess their cytotoxicity. In addition, a rabbit xenograft model of retinoblastoma was developed to test the antitumor effectiveness of TPH-CMD-TCS-NPs through intravitreal administration. Results: NPs had a mean diameter, polydispersity index, and zeta potential of 30 ± 4 nm, 0.24 ± 0.03 and +10 ± 3 mV, respectively. NPs (IC50s 40.40 compared to 126.20 nM, P = 0.022) were more effective than free topotecan as a dose-based feature. The tumor reaction to intravitreal chemotherapy with NPs was measured by evaluating the percentage of necrosis in the tumor tissue (91 ± 2%) and vitreous seeds (89 ± 9%) through hematoxylin and eosin (H&E) staining. In comparison with the control group, the TPH-CMD-TCs-NPs treated group showed a significant decrease in tumor volume seven days after the intravitreal injection (P = 0.039). No significant changes were found in the ERG parameters after the intravitreal injection of TPH-CMD-TCs-NPs or TPH (P > 0.05). Conclusion: This investigation revealed definitive antitumor efficacy of TPH-CMD-TCS-NPs by intravitreal administration in the rabbit xenograft retinoblastoma model.
      pubtype: Academic Journal
      doctype:
        diagnostic images
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N